Lateral flow tests are performed to detect the presence of target analyte in the sample and are also known as lateral flow immunotechnology assays. Such tests are used for medical diagnostics either for home testing, point of care testing, or laboratory use. The APAC lateral flow diagnostic tests market is expected to grow at a moderate rate due to rising prevalence of infectious diseases, increasing government initiatives and product innovation by various medical companies.
Based on application, the APAC lateral flow diagnostic tests market has been segmented into pregnancy, hepatitis, HIV, influenza, syphilis, malaria, and other tests which include lung disorders, cardiac markers, drug abuse, etc. The pregnancy application segment dominated the APAC lateral flow diagnostic tests market accounting for the share of 26.4% in 2014. Increasing birth rate in Asia Pacific and easy-to-use tests kits are a few of the factors responsible for the high market share of pregnancy application segment. However, hepatitis application segment is expected to foresee the highest growth rate during the forecast period due to increasing prevalence of immunological disorders. In addition, the usage of lateral flow diagnostic test kits require minimal education for users and regulators, hence driving the growth of the hepatitis application segment in the near future.
Geographically, Japan dominated the APAC lateral flow diagnostic tests market in 2014 with a share of 22.0% due to factors such as advancements in product designs and technologies and government initiatives related to awareness of infectious diseases among the people. Rising prevalence of life-threatening diseases and increasing birth rate are the other factors supporting the market growth in Japing. Indonesia is projected to be the most lucrative market for lateral flow diagnostic tests and is expected to expand at the highest growth rate of 9.2% from 2015 to 2023. Factors propelling the growth of the lateral flow diagnostic tests market in Indonesia are increasing number of population, an efficient healthcare system, and rising health care awareness among the people.
Major players in the APAC lateral flow diagnostic tests market include Alere, Inc., Beckman Coulter, Inc., Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, EMD Millipore, F. Hoffmann-La Roche Ltd., Siemens Healthcare, and QIAGEN. These players are involved in constant product development and competition with each other.